Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)

NCT06494111 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

295

Enrollment

OTHER

Sponsor class

Conditions

Lymphedema
Fibrosis

Interventions

DRUG: Pravastatin
DRUG: Pentoxifylline
DRUG: Tocopherol

Sponsor

M.D. Anderson Cancer Center